Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 825 results for "novartis ag"

Novartis India tumbles as buyback plan disappoints investors

Novartis India slumped 12.06% to Rs 728 at 12:30 IST on BSE after the company's buyback plan disappointed investors. The company announced its buyback plan after market hours yesterday, 26 May 2016. Meanwhile, the S&P BSE Sensex was up 181.32 ... Capital Market, 2 days ago

22 images for novartis ag

Drug Development Technology, 1 day ago
Business Insider, 1 week ago
Business Insider, 1 week ago
Reuters India, 1 week ago
MyNewsDesk, 4 days ago
Schaeffers Research, 1 week ago
Channel NewsAsia, 1 week ago
Nasdaq, 1 week ago
Nasdaq, 1 week ago
BioSpace, 1 week ago

Novartis board okays buyback

Drugmaker Novartis said on Thursday its board of directors has unanimously approved a buyback proposal for the purchase of the company's shares at ₹760 per share. The company's shares on the BSE closed on Thursday at ₹827, after the stock had ...
 Hindu Business Line2 days ago Novartis to consider buyback at Thursday board meet  Business Line4 days ago
Financial Express

Novartis India to buy back shares worth Rs 290 crore

Novartis India, which sells the oncology drug Glivec, said on Thursday it will buy back shares worth Rs 290 crore. In a stock exchange filing, the pharmaceutical company said it would acquire close to 38 lakh shares at a price of Rs 760 a share. The ...
 Financial Express2 days ago
4 Traders

Novartis' CEO Says Company Open To Selling Its $14 Billion Stake In Roche 'If The Opportunity Were Right'

Switzerland-based Novartis AG (ADR) (NYSE: NVS ) owns a roughly $14 billion stake in rival Roche Holding Ltd. (ADR) (OTC: RHHBY ) and is actively shopping for buyers to acquire its stake. According to Reuters, Novartis has been working with ...
 Benzinga.com3 days ago Novartis willing to sell Roche stake without demanding premium - CEO  4 Traders4 days ago

Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT (Influenza Vaccine) for people four years of age and older

the CSL Group and its Affiliates acquired the influenza vaccines business of Novartis AG in the US. The influenza vaccines business, previously owned by Novartis, has been integrated into CSL's influenza vaccine business and now operates as Seqirus.
 Benzinga.com5 days ago FLUAD(TM) (influenza vaccine, adjuvanted) to Help Protect Elderly Patients Against Influenza  Pharmacy Times5 days ago 5/24/16 - Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT?¢ (Influenza Vaccine) for people four years of age and older  Pharmacy Choice5 days ago

Novartis India surges on share buyback plans

Email this Print Novartis India has surged 15% to Rs 818 on the BSE in early morning trade after the pharmaceutical company announced that its board will meet on Thursday, May 26, 2016, to consider a proposal for buyback of the company's equity ...
 Smart Investor5 days ago

Troikaa Pharmaceuticals moves HC on grant of licences to Novartis injection

Troikaa pharmaceutical alleged that the approval for manufacturing and marketing of the injection is arbitrary in view of safety concerns over Transcutol New Delhi: The Delhi high court on Friday sought a response from the centre, Novartis India and ...
 Livemint.com1 week ago
Bidness Etc

Novartis Continues Efforts To Gain Larger Market For Entresto

Novartis is putting its utmost efforts into eradicating the sluggish acceptance pattern of the drug in the medical community Novartis AG (ADR) ( NYSE:NVS ) is working diligently to bring back heart failure drug Entresto, after the drug's ...
 Bidness Etc1 week ago

Novartis Announces The Establishment Of FortiHFy, But What Is It?

Novartis AG (ADR) (NYSE: NVS ) announced on Thursday the establishment of FortiHFy, short for Forti fying H eart F ailure clinical evidence and patient qualit y of life. FortiHFy is an umbrella clinical program that consists of over 40 active or ...
 Benzinga.com1 week ago
4 Traders

Novartis Restructuring Decision Surprising But Possibly Smart

Novartis head of pharmaceuticals to leave the company as his role gets split into two Novartis AG (ADR) ( NYSE:NVS ) announced on Tuesday the departure of its head of pharmaceuticals, David Epstein, as the company restructures its business ...
 Bidness Etc1 week ago Novartis Splits Up Drug Unit as Top Executive Will Depart  Bloomberg1 week ago Novartis AG's Pharma Head Exits as Drug Business is Split into Two  BioSpace1 week ago Novartis Says Drug-Unit Chief To Leave Firm -- WSJ  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - novartis ag
Get updated on latest news & your favorite topics right in your inbox!
More     Less